- Home
- WFG vs LNTH Comparison
WFG vs LNTH Comparison
Compare WFG & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WFG | LNTH |
|---|---|---|
| Founded | 1955 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | WFG | LNTH |
|---|---|---|
| Price | $60.58 | $66.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $93.00 | $78.00 |
| AVG Volume (30 Days) | 237.4K | ★ 1.2M |
| Earning Date | 02-11-2026 | 11-06-2025 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | ★ $5,702,000,000.00 | $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | $9.45 | $0.52 |
| P/E Ratio | ★ N/A | $27.87 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $57.34 | $47.25 |
| 52 Week High | $93.03 | $111.29 |
Technical Indicators
Market Signals| Indicator | WFG | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 65.42 |
| Support Level | $58.81 | $64.13 |
| Resistance Level | $60.74 | $68.84 |
| Average True Range (ATR) | 1.56 | 1.91 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 43.04 | 75.07 |
Price Performance
Historical ComparisonAbout WFG West Fraser Timber Co. Ltd.
West Fraser Timber is a softwood lumber company that also produces wood panels and pulp products. The company produces its wood products globally, with lumber mills in British Columbia, Alberta, Europe, and the Southeastern United States. Following its acquisition of Norbord in 2021, West Fraser is one of the largest oriented strand board producers in the world.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.